Amylyx Pharmaceuticals, Inc. (AMLX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading AMLX…

Amylyx Pharmaceuticals, Inc. (AMLX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Amylyx Pharmaceuticals, Inc.

AMLX · CIK 1658551

4 · Sep 14, 2026 · Chief Financial Officer FRATES JAMES M sold 10.81K shares at $32.36/share ($349.8K)

4

Chief Financial Officer FRATES JAMES M sold 10.81K shares at $32.36/share ($349.8K)

Filed: Sep 14, 2026
Period: Sep 10, 2026
Accession: 0001193125-26-390509
Filer: Amylyx Pharmaceuticals, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov